Curriculum Vitae Medical Researcher in Germany Frankfurt – Free Word Template Download with AI

Name: Dr. Emily Hartmann

Email: [email protected]

Phone: +49 170 1234567

Address: Frankfurt am Main, Germany

A dedicated Medical Researcher with over 8 years of experience in advancing biomedical innovations and translational research. Specialized in clinical trials, molecular biology, and public health policies. Committed to contributing to the scientific community in Germany Frankfurt through cutting-edge research aligned with the region’s reputation as a hub for medical innovation. Proficient in German and English, with a strong network of collaborations across European research institutions.

• Ph.D. in Medical Sciences, Goethe University Frankfurt (Germany) – 2015
• M.Sc. in Molecular Biology, University of Heidelberg (Germany) – 2010
• B.Sc. in Biomedical Sciences, Ludwig Maximilian University Munich (Germany) – 2007

Senior Medical Researcher

Frankfurt Institute for Biomedical Innovation (FIBI), Germany Frankfurt – 2018–Present

• Lead research on cancer immunotherapy, focusing on personalized treatment strategies for solid tumors.
• Collaborated with the German Cancer Society (DKG) to design and execute phase II clinical trials in Frankfurt.
• Published 12 peer-reviewed articles in high-impact journals such as *Nature Medicine* and *The Lancet Oncology*.
• Secured €2.5 million in funding from the European Union’s Horizon 2020 program for a five-year project on neuro-oncology.

Postdoctoral Research Fellow

Institute of Experimental Medicine, Goethe University Frankfurt – 2015–2018

• Conducted research on neurodegenerative diseases, including Alzheimer’s and Parkinson’s.
• Developed a novel biomarker panel for early detection of Alzheimer’s, published in *JAMA Neurology* (2017).
• Mentored 4 Ph.D. students and 2 postdocs in laboratory techniques and data analysis.

Research Assistant

Max Planck Institute for Biomedical Research, Germany – 2010–2015

• Contributed to a EU-funded project on gene editing using CRISPR-Cas9 technology.
• Collaborated with the German Federal Ministry of Health to evaluate the ethical implications of genetic modification.
• Presented findings at international conferences in Berlin, Vienna, and Zurich.

• Cancer immunotherapy and targeted therapies
• Neurodegenerative disease mechanisms
• Biomarker discovery and diagnostic tools
• Translational research connecting lab findings to clinical applications

• Hartmann, E., et al. (2023). "Targeting Tumor Microenvironment in Pancreatic Cancer: A Novel Immunotherapy Approach." *Nature Medicine*, 19(4), 567–578.
• Hartmann, E., & Müller, R. (2021). "Early Detection of Alzheimer’s Using Blood-Based Biomarkers." *The Lancet Neurology*, 20(3), 210–219.
• Hartmann, E. (2019). "Ethical Considerations in CRISPR-Cas9 Applications." *Journal of Medical Ethics*, 45(6), 387–394.

• Laboratory techniques: PCR, ELISA, flow cytometry, next-generation sequencing
• Data analysis: R, Python, SPSS, bioinformatics tools (e.g., Bioconductor)
• Project management and grant writing
• Interdisciplinary collaboration across clinical and academic settings

• German – Native speaker (C2 level)
• English – Fluent (C1 level), with publications and presentations in English-speaking journals

• Good Clinical Practice (GCP) Certification – 2018 (European Medicines Agency)
• Advanced Bioinformatics Training – 2017 (EMBL-EBI, Heidelberg)
• Ethics in Biomedical Research – 2016 (Max Planck Society)

• Member, German Cancer Society (DKG)
• Member, European Society for Medical Oncology (ESMO)
• Reviewer, *Nature Medicine* and *The Lancet Oncology*

Available upon request.